Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients
- 1 March 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 84 (3) , 581-589
- https://doi.org/10.1016/0002-9343(88)90140-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Aztreonam therapy in neutropenic patients with cancerThe American Journal of Medicine, 1986
- Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patientsAntimicrobial Agents and Chemotherapy, 1986
- Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patientsThe American Journal of Medicine, 1984
- A Randomized Study of Tobramycin Plus Ticarcillin, Tobramycin Plus Cephalothin and Ticarcillin, or Tobramycin Plus Mezlocillin in the Treatment of Infection in Neutropenic Patients with MalignanciesThe Lancet Healthy Longevity, 1984
- A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patientsJournal of Antimicrobial Chemotherapy, 1983
- Fever in the Pediatric and Young Adult Patient with CancerMedicine, 1982
- A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patientsThe American Journal of Medicine, 1979
- Therapy of Infection in Patients with GranulocytopeniaMedical Clinics of North America, 1977
- Gram-Negative Infections in CancerJAMA, 1974